# Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

> **NCT02988466** · PHASE2 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 78 (actual)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **BIOLOGICAL:** Haplo HCT <55 years old
- **BIOLOGICAL:** Haplo HCT ≥55 years old
- **DRUG:** GVHD Prophylaxis
- **BIOLOGICAL:** Haplo HCT ≥55 and < 65 years old
- **BIOLOGICAL:** Haplo HCT ≥65 and ≤75 years old

## Key facts

- **NCT ID:** NCT02988466
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-24
- **Primary completion:** 2023-05-02
- **Final completion:** 2025-03-24
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02988466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02988466, "Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02988466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*